Safety and Efficacy in HIV-1-Infected Patients Treated with Ritonavir-Boosted Saquinavir Mesylate. - Wikidata - awgldk - TriplyDB

Safety and Efficacy in HIV-1-Infected Patients Treated with Ritonavir-Boosted Saquinavir Mesylate.

Safety and Efficacy in HIV-1-Infected Patients Treated with Ritonavir-Boosted Saquinavir Mesylate.

http://www.wikidata.org/entity/Q33794298

about

HIV protease inhibitors in pulmonary hypertension: rationale and design of a pilot trial in idiopathic pulmonary arterial hypertension.Dolutegravir/rilpivirine for the treatment of HIV-1 infection

P2860

Q36016529-6CE7FDD9-F406-4D81-BB44-2C69E82CD48C Q59135153-775006C5-6129-440B-AF59-6094A3B87B50

P2860

Safety and Efficacy in HIV-1-Infected Patients Treated with Ritonavir-Boosted Saquinavir Mesylate.

http://www.wikidata.org/entity/Q33794298

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Safety and Efficacy in HIV-1-I ...... r-Boosted Saquinavir Mesylate.

@ast

Safety and Efficacy in HIV-1-I ...... r-Boosted Saquinavir Mesylate.

@en

type

label

Safety and Efficacy in HIV-1-I ...... r-Boosted Saquinavir Mesylate.

@ast

Safety and Efficacy in HIV-1-I ...... r-Boosted Saquinavir Mesylate.

@en

prefLabel

Safety and Efficacy in HIV-1-I ...... r-Boosted Saquinavir Mesylate.

@ast

Safety and Efficacy in HIV-1-I ...... r-Boosted Saquinavir Mesylate.

@en

P1433

Q33794298-E1E34F01-CC30-4953-90A6-E23F605BC876

P1476

Q33794298-29663D82-E259-4F39-A573-B32B00256CCC

P2093

Q33794298-451793B3-92B1-4B39-980F-D2FCD269852E

Q33794298-4BF07349-3767-469A-8051-D45FA5B49D48

Q33794298-7DA2E085-8845-4B59-AB69-74E4220F9F62

Q33794298-B41913CB-E177-4193-A550-93AAF84546ED

Q33794298-B4890151-0AC0-4985-B04C-B3CDD71962A7

Q33794298-E38CB1E4-0D05-42DD-B89B-FCD12F45442E

P2860

Q33794298-274BF368-08DE-48CD-A65B-14808F4D90A7

Q33794298-61B6EA3E-8B70-4CE1-9D3F-0AF71B658B94

Q33794298-715B1AA1-1F79-4B61-8522-BFFD833FADFE

Q33794298-8292DEBC-9F2A-45A3-B08E-D1786E891D34

Q33794298-86C6A2BA-6FDF-47F1-A45F-AD1934CDC45F

Q33794298-92BEE8C8-5C61-484D-8E64-C4D374FC86AF

Q33794298-A34D8F83-E132-4A05-934E-794BACEE4603

Q33794298-E192EB16-487C-48F7-9989-3AD8173F7525

Q33794298-FAE28985-2572-4E7A-81BA-DABC3F1A342B

P304

Q33794298-86DF0711-E1FF-4337-B4CC-32726AD8E413

P31

Q33794298-3DC5045B-DBAA-4851-8740-B466EB0C3281

P356

Q33794298-C1E6DFD0-6345-4863-8DF8-B45EB23A8CA8

P433

Q33794298-BDFC4045-5ADB-441A-9918-FFD3813FE6EA

P478

Q33794298-92C708CF-6275-480F-809B-5E3D05596CF6

P50

Q33794298-11A1780C-FA75-4367-8DFC-54310CE217D7

P577

Q33794298-AD998FBC-872E-47CC-BA5D-7E7F77D55A59

P5875

Q33794298-8458735B-62E1-4067-B925-A48BA735A81F

P698

Q33794298-ABB4124F-D768-4474-B2D3-A1B9F7B9F37D

P932

Q33794298-FFBC7ED5-E891-40FA-8197-A111EEE4DB71

P356

J.1753-5174.2009.00028.X

P1433

Archives of Drug Information

P1476

Safety and Efficacy in HIV-1-I ...... r-Boosted Saquinavir Mesylate.

@en

P2093

Andre Tappe

http://www.w3.org/2001/XMLSchema#string

Hans Jaeger

http://www.w3.org/2001/XMLSchema#string

Heribert Knechten

http://www.w3.org/2001/XMLSchema#string

Piotr Pulik

http://www.w3.org/2001/XMLSchema#string

Teodoro Martin

http://www.w3.org/2001/XMLSchema#string

Thomas Lutz

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.

Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.

Gemini: a noninferiority study of saquinavir/ritonavir versus lopinavir/ritonavir as initial HIV-1 therapy in adults.

A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial.

Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.

Unmeasured confounding caused slightly better response to HAART within than outside a randomized controlled trial.

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults.

P304

26-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1753-5174.2009.00028.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Heribert Knechten

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43352210

http://www.w3.org/2001/XMLSchema#string

P698

20428230

http://www.w3.org/2001/XMLSchema#string

P932

2855836

http://www.w3.org/2001/XMLSchema#string